ResMed (RMD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period What does JP Morgan think Resmed shares are worth after reviewing its FY25 result?August 4 at 2:52 AM | msn.comUS$290 - That's What Analysts Think ResMed Inc. (NYSE:RMD) Is Worth After These ResultsAugust 2, 2025 | finance.yahoo.comThe Analyst Verdict: ResMed In The Eyes Of 8 ExpertsAugust 1, 2025 | benzinga.comResMed (NYSE:RMD) Surprises With Q2 SalesJuly 31, 2025 | msn.comCalculating The Intrinsic Value Of ResMed Inc. (NYSE:RMD)July 29, 2025 | finance.yahoo.comHere's What to Expect From ResMed's Next Earnings ReportJuly 24, 2025 | msn.com2 Reasons to Watch RMD and 1 to Stay CautiousJuly 15, 2025 | msn.com2 S&P 500 Stocks with Promising Prospects and 1 to Steer Clear OfJuly 9, 2025 | finance.yahoo.comAll You Need to Know About ResMed (RMD) Rating Upgrade to Buy - Yahoo FinanceJune 27, 2025 | finance.yahoo.comIs the ResMed share price still cheap? What the numbers sayJune 19, 2025 | msn.comResMed’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJune 18, 2025 | msn.comResMed Stock: Is RMD Outperforming the Healthcare Sector?June 16, 2025 | msn.com2 Large-Cap Stocks with Competitive Advantages and 1 to Approach with CautionJune 9, 2025 | finance.yahoo.comUp more than 75% since October 2023 — are ResMed shares a buy, hold or sell?June 4, 2025 | msn.com1 Surging Stock with Exciting Potential and 2 to AvoidMay 23, 2025 | finance.yahoo.comAre Wall Street Analysts Bullish on ResMed Stock?May 23, 2025 | msn.comShould you buy the dip in the ResMed share price?May 20, 2025 | msn.comResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s UnmovedMay 20, 2025 | msn.com1 Unpopular Stock that Should Get More Attention and 2 to Brush OffMay 20, 2025 | finance.yahoo.com2 super ASX 200 blue chip shares to buy nowMay 18, 2025 | msn.comJim Cramer Says The Day “Everything’s A Lot More Expensive” Is Coming & Discusses These 10 StocksApril 30, 2025 | insidermonkey.comResmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?April 30, 2025 | msn.comMorgans Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)April 28, 2025 | markets.businessinsider.comRMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define QuarterApril 26, 2025 | msn.comResMed price target raised to $274 from $269 at KeyBancApril 25, 2025 | markets.businessinsider.comResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...April 24, 2025 | finance.yahoo.comMagnificent 7 Earnings Out this Week will Shed Light on Big Tech’s Tariff ConcernsApril 23, 2025 | theglobeandmail.com2RMD : Assessing ResMed: Insights From 5 Financial AnalystsApril 21, 2025 | benzinga.comResMed price target lowered to $268 from $280 at KeyBancApril 21, 2025 | markets.businessinsider.comResMed price target lowered to $265 from $280 at MizuhoApril 16, 2025 | markets.businessinsider.comResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Morgan StanleyApril 15, 2025 | markets.businessinsider.comResmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Goldman SachsApril 14, 2025 | markets.businessinsider.comEarnings Preview: What to Expect From ResMed’s ReportApril 14, 2025 | msn.comResMed placed on ‘downside 90-day catalyst watch’ at CitiApril 11, 2025 | markets.businessinsider.comResMed announces availability of home sleep apnea test NightOwlApril 3, 2025 | markets.businessinsider.comResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across USApril 3, 2025 | finance.yahoo.comResMed price target lowered to $280 from $290 at BofAApril 3, 2025 | markets.businessinsider.comJim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings SeasonApril 2, 2025 | insidermonkey.comIs ResMed Stock Outperforming the Dow?March 20, 2025 | msn.comGoldman Sachs Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)March 11, 2025 | markets.businessinsider.com2 ASX healthcare shares rated as top buysMarch 5, 2025 | fool.com.auResMed upgraded to Buy from Neutral at CitiMarch 5, 2025 | markets.businessinsider.comResMed price target lowered to $240 from $250 at StifelMarch 5, 2025 | markets.businessinsider.com2 Reasons to Like RMD and 1 to Stay SkepticalMarch 4, 2025 | msn.comThe ultimate ASX growth shares to buy with $2,000 in MarchMarch 4, 2025 | msn.comResMed Inc. (NYSE:RMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?February 24, 2025 | finance.yahoo.comWith 69% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backingFebruary 9, 2025 | finance.yahoo.comLooking to bag the record high ResMed dividend? You better hurry!February 5, 2025 | msn.comWilsons downgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a HoldFebruary 3, 2025 | markets.businessinsider.comUBS upgrades Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) to a BuyFebruary 3, 2025 | markets.businessinsider.com Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address RMD Media Mentions By Week RMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RMD News Sentiment▼0.770.39▲Average Medical News Sentiment RMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RMD Articles This Week▼52▲RMD Articles Average Week Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GE HealthCare Technologies News Today Koninklijke Philips News Today Zimmer Biomet News Today Smith & Nephew SNATS News Today Solventum News Today Penumbra News Today Stevanato Group News Today Glaukos News Today Bausch + Lomb News Today iRhythm Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:RMD) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
